HIV-PROTEASEINHIBITOREN

European patent · EP0695184 · Deleted

Register entry

Publication number
EP0695184
Application number
EP94907199
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 18, 1994
Published
Feb 7, 1996
Granted
Apr 21, 1999
Deleted
Apr 21, 1999
Reason
No effect for Switzerland and Liechtenstein
IPC classes
C07C 235/42 (2006.01)
C07C 235/66 (2006.01)
C07C 323/60 (2006.01)
C07C 323/63 (2006.01)
C07C 237/30 (2006.01)
C07C 323/62 (2006.01)
C07D 211/78 (2006.01)
C07D 213/74 (2006.01)
C07D 213/81 (2006.01)
C07D 215/08 (2006.01)
C07D 217/06 (2006.01)
A61K 31/165 (2006.01)
Priority
US 5150 15.01.1993
US 42261 02.04.1993
US 99375 30.07.1993
PCT application
PCT/US1994/000419 18.01.1994
PCT publication
WO1994/015608 21.07.1994
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 29, 1999

    Change

    Published in PIDTJ No 20 in 1999

  2. Apr 30, 1999

    Granted

    Published in PIDTJ No 8 in 1999

Parties

Holder

Agouron Pharmaceuticals, Inc.

AGOURON PHARMACEUTICALS, INC.

3565 General Atomics Court, San Diego, CA 92121, US

Inventor

REICH, Siegfried, H.

San Diego, CA 92104, US

LEWIS, Kathleen

San Diego, CA 92129, US

MELNICK, Michael

San Diego, CA 92111, US

FUHRY, Mary Ann M.

APO AEO 9459, US

KALDOR, Stephen, Warren

Indianapolis, IN 46254, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.